Jamjoom Pharmaceuticals Factory Company (4015.SR) SAU
155.10
+0.3(+0.19%)
Currency In SAR
- General
- Statistics
- Historical Data
- Profile
- Financials
155.10
+0.3(+0.19%)
Currency In SAR
| Market Cap | 10B |
| Enterprise Value | 9.66B |
| P/E Ratio | 22.89 |
| PEG Ratio | 1.43 |
| Price/Sales Ratio | 7.12 |
| Price/Book Ratio | 6.29 |
| Enterprise/Revenue | 7 |
| Enterprise/EBITDA | 20.68 |
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | March 31, 2026 |
| Profit Margin | 0.31 |
| Operating Margin | 0.32 |
| Return On Assets | 0.23 |
| Return On Equity | 0.28 |
| Revenue | 1.5B |
| Revenue/Share | 21.75 |
| Gross Profit | 938.8M |
| EBITDA | 474.8M |
| Net Income | 463.8M |
| Diluted EPS | 6.6 |
| Total Cash | 206.7M |
| Total Cash/Share | 2.95 |
| Total Debt | 20.77M |
| Total Debt/Equity | 0.01 |
| Current Ratio | 4.94 |
| Book Value Per Share | 24.68 |
| 52-Week Change | -10.86 |
| 52-Week High | 181.3 |
| 52-Week Low | 125 |
| Moving Average 50 Days | 153.03 |
| Moving Average 200 Days | 147.79 |
| Average Volume | 101,464 |
| Shares Outstanding | 70M |
| % Held by Institutions | N/A |
| Trailing Annual Dividend Rate | 4 |
| Trailing Annual Dividend Yield | 2.58 |
| Payout Ratio | 0.59 |
| Last Split Factor | N/A |
| Last Split Date | N/A |